This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignees: Mylan Pharmaceuticals Inc., Sandoz Ag. Active years: 2017-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2020
Title: Ulrich Kurt Blaschke: Innovator in G-CSF Purification Methods
Introduction
Ulrich Kurt Blaschke is a notable inventor based in Wiesbaden, Germany. He has made significant contributions to the field of biotechnology, particularly in the purification of recombinant proteins. With a total of 2 patents, his work has advanced the methods used in the pharmaceutical industry.
Latest Patents
Blaschke's latest patents focus on a method for the purification of granulocyte-colony stimulating factor (G-CSF). This method involves at least one cation exchange chromatography and at least one hydrophobic interaction chromatography. The innovative approach allows for the effective purification of G-CSF from a mixture of proteins, enhancing the efficiency of the process.
Career Highlights
Throughout his career, Ulrich Kurt Blaschke has worked with prominent companies in the pharmaceutical sector, including Mylan Pharmaceuticals Inc. and Sandoz AG. His expertise in protein purification has made him a valuable asset in these organizations.
Collaborations
Blaschke has collaborated with notable professionals in his field, including Arndt Dietrich and Bernhard Janowski. These partnerships have contributed to the development of his innovative purification methods.
Conclusion
Ulrich Kurt Blaschke's contributions to the purification of G-CSF represent a significant advancement in biotechnology. His patents and collaborations reflect his commitment to innovation in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile